IMPA1 Antikörper
Kurzübersicht für IMPA1 Antikörper (ABIN7467238)
Target
Alle IMPA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Kreuzreaktivität
 - Human
 - 
                                            
Aufreinigung
 - Purified by antigen-affinity chromatography.
 - 
                                            
Immunogen
 - Full length human IMPA1 Recombinant protein.
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
 - 
                                            
Kommentare
 - 
                        
Positive Control: PC-3 , SK-N-SH
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Konzentration
 - 1 mg/mL
 - 
                                            
Buffer
 - 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
 - 
                                            
Konservierungsmittel
 - Thimerosal (Merthiolate)
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
 
 - 
                                            
 - 
    
- IMPA1 (Inositol(myo)-1(or 4)-Monophosphatase 1 (IMPA1))
 - 
                                            
Andere Bezeichnung
 - inositol monophosphatase 1
 - 
                                            
Hintergrund
 - Inositol monophosphatase 1 , IMP , IMPA , MRT59,This gene encodes an enyzme that dephosphorylates myo-inositol monophosphate to generate free myo-inositol, a precursor of phosphatidylinositol, and is therefore an important modulator of intracellular signal transduction via the production of the second messengers myoinositol 1,4,5-trisphosphate and diacylglycerol. This enzyme can also use myo-inositol-1,3-diphosphate, myo-inositol-1,4-diphosphate, scyllo-inositol-phosphate, glucose-1-phosphate, glucose-6-phosphate, fructose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. This enzyme shows magnesium-dependent phosphatase activity and is inhibited by therapeutic concentrations of lithium. Inhibition of inositol monophosphate hydroylosis and subsequent depletion of inositol for phosphatidylinositol synthesis may explain the anti-manic and anti-depressive effects of lithium administered to treat bipolar disorder. Alternative splicing results in multiple transcript variants encoding distinct isoforms. A pseudogene of this gene is also present on chromosome 8q21.13. [provided by RefSeq]
 - 
                                            
Molekulargewicht
 - 30 kDa
 - 
                                            
Gen-ID
 - 3612
 - 
                                            
UniProt
 - P29218
 
Target
 -